Pharmafile Logo

Redefining digital ROI: Engagement, experience, and the new metrics of success

December 18, 2025 | Engagement, RoI, experience 

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and omnichannel initiatives.

- PMLiVE

As pressure grows on pharma teams to prove the value of their digital initiatives, traditional KPIs are falling short. Engagement rates and click-throughs only tell part of the story. What matters now is meaningful impact – for your audience, and your business.

In this webinar, we explored how pharma teams can evolve their digital measurement frameworks to capture what really counts. We discussed why traditional KPIs fall short in today’s pharma landscape, how to link engagement and experience to real-world outcomes, what ROI really means for digital and omnichannel investment and how to build actionable, insight-led measurement frameworks.

Latief Ziada, from Graphite, was joined by two expert panellists — Alyssa Fenoglio, Global Head of Digital Commercial, Teva Pharmaceuticals, and Florent Edouard, Global Head of the Digital Accelerator, Sanofi.

If you’re involved in digital decision-making within pharma, check it out.

Disclaimer: The opinions shared by our panellists are solely their own and should not be taken as representative of their organisations.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

5 key digital CX challenges in pharma, and how to start solving them

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

Driving behaviour change for positive patient outcomes in pharma

Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...

How to successfully manage change and enable digital transformation within pharma

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Ensuring a seamless transition from design to development: Strategies for successful collaboration

When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.

How user research will help you create better digital products, whatever stage you’re at

User research provides valuable insight that will help you create better digital products and services, whatever stage you’re at.